HSCS (HeartSciences) Tariff Resilience Score: 6/10 (As of Jun. 29, 2026)


HSCS HeartSciences Inc HSCS
42 GF Score
Price $2.72
GF Value $2.61
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is HeartSciences Tariff Resilience Score?

HeartSciences HSCS -5.17% 42 Tariff Resilience Score is 6 as of Jun. 29, 2026. GuruFocus rates HSCS with a GF Score™ of 42/100 and a GF Value™ of $2.61 (Fairly Valued). The stock has 7 warning signs investors should review. Among 838 Medical Devices & Instruments companies, HeartSciences ranks better than 91.05% on this metric.

HeartSciences has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

HeartSciences has HeartSciences relies on global suppliers for components, but medical device exemptions can mitigate tariff impacts. Its innovative products may offer some pricing power to offset increased costs.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes HeartSciences might have Average Resilient.

HeartSciences  (NAS:HSCS) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

HeartSciences Tariff Resilience Score Related Terms

HSCS vs CSDX, CODX, ALRTF: Tariff Resilience Score Comparison

For the Medical Devices subindustry, HeartSciences's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HeartSciences Tariff Resilience Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeartSciences's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where HeartSciences's Tariff Resilience Score falls into.


HSCS
42GF Score
HeartSciences Inc HSCS
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
HeartSciences (HSCS) has a Tariff Resilience Score of 6 as of Jun. 29, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, HeartSciences ranks #75 out of 838 companies in the Medical Devices & Instruments industry, placing it in the top 8.9%.
Is HeartSciences' Tariff Resilience Score too high?
HeartSciences' current Tariff Resilience Score is 6. Based on the distribution chart, HeartSciences ranks #75 out of 838 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, HeartSciences has a GF Score™ of 42/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does HeartSciences' Tariff Resilience Score compare to CSDX and CODX?
According to the Medical Devices & Instruments industry distribution chart, HeartSciences ranks #75 out of 838 companies for Tariff Resilience Score. This places HeartSciences in the top 9% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Devices & Instruments company?
A good Tariff Resilience Score depends on the Medical Devices & Instruments industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. HeartSciences's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HeartSciences stock overvalued right now?
Based on GuruFocus' analysis, HeartSciences (HSCS) is currently considered Fairly Valued. The stock's GF Value™ is $2.61, compared to a current price of $2.72 — trading 4.2% above its estimated fair value. The current Tariff Resilience Score is 6. HeartSciences' overall GF Score™ is 42/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For HeartSciences (HSCS), the current Tariff Resilience Score is 6 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is HeartSciences (HSCS) Overvalued in 2026?

Based on GuruFocus' analysis, HeartSciences stock appears to be overvalued. The current stock price of $2.72 is trading 4.2% above its estimated GF Value™ of $2.61. GuruFocus considers HeartSciences to be Fairly Valued.

Key valuation signals for HSCS:

  • Tariff Resilience Score: 6
  • GF Value™: $2.61 vs. price of $2.72 (4.2% above fair value)
  • GF Score™: 42/100 with 7 warning signs

No single metric tells the full story. See the HSCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

HeartSciences Business Description

Address 550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
42GF Score

Get the complete analysis for HSCS

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.72
Price
$2.61
GF Value